These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast. Williams MR; Perkins AC; Campbell FC; Pimm MV; Hardy JG; Wastie ML; Blamey RW; Baldwin RW Clin Oncol; 1984 Dec; 10(4):375-81. PubMed ID: 6391773 [TBL] [Abstract][Full Text] [Related]
18. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments. Kalofonos HP; Sivolapenko GB; Courtenay-Luck NS; Snook DE; Hooker GR; Winter R; McKenzie CG; Taylor-Papadimitriou JJ; Lavender PJ; Epenetos AA Cancer Res; 1988 Apr; 48(7):1977-84. PubMed ID: 2832056 [TBL] [Abstract][Full Text] [Related]
19. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353 [TBL] [Abstract][Full Text] [Related]
20. [Use of radionuclide diagnostic methods in the detection of distant metastases of lung cancer]. Zubov GS; Fadeev NP; Mitreĭkin VF; Keller IuM Med Radiol (Mosk); 1984 Jan; 29(1):18-21. PubMed ID: 6694539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]